13th International forum on
Pharma Patent Extensions
Wednesday, June 25 to Thursday, June 26, 2014
It is critical time in the industry of pharma patents. The decisions handed down (late last year) in the Actavis, Medeva and Lilly cases will have profound implications for pharma patentees. The implementation of the Unified Patent Court continues to raise questions and issues which must be critically addressed. Amendments to UK legislation relating to the Bolar exemption must be evaluated.
The 13th International Forum on Pharma Patent Extensions will address the pressing concerns and issues facing the industry at present. It will bring together eminent in-house counsel from the world’s largest pharma companies and their expert advisors from a range of jurisdictions, including the US, Europe and beyond.
The Forum will provide a critical insight into the significant changes, updates and forecasts. Plus unparalleled learning prospects including, top tips, strategies and tactics to ensure you maximise your opportunities to optimise the life-cycle of your patents and implement the most practical and cost effective procedures.
The diverse and international panellists will address the pressing and newest topics including:
Be where your industry will be on 25th
and 26th June 2014 and don’t miss out on this unique opportunity
to hear from and network with prominent judicial authorities, regulatory
experts and industry specialists.
Marketing and media support enquiries:
Nathan Denham, C5
Evi Kartsouni, C5
Tel: +44 (0) 20 7878 6955
- Actions -
- Share -
Wed, Jun 25, 2014
Thu, Jun 26, 2014